Cargando…
Roflumilast Inhibits Respiratory Syncytial Virus Infection in Human Differentiated Bronchial Epithelial Cells
Respiratory syncytial virus (RSV) causes acute exacerbations in COPD and asthma. RSV infects bronchial epithelial cells (HBE) that trigger RSV associated lung pathology. This study explores whether the phosphodiesterase 4 (PDE4) inhibitor Roflumilast N-oxide (RNO), alters RSV infection of well-diffe...
Autores principales: | Mata, Manuel, Martinez, Isidoro, Melero, Jose A., Tenor, Herman, Cortijo, Julio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3720563/ https://www.ncbi.nlm.nih.gov/pubmed/23936072 http://dx.doi.org/10.1371/journal.pone.0069670 |
Ejemplares similares
-
Respiratory Syncytial Virus Inhibits Ciliagenesis in Differentiated Normal Human Bronchial Epithelial Cells: Effectiveness of N-Acetylcysteine
por: Mata, Manuel, et al.
Publicado: (2012) -
Roflumilast Prevents the Metabolic Effects of Bleomycin-Induced Fibrosis in a Murine Model
por: Milara, Javier, et al.
Publicado: (2015) -
Roflumilast improves corticosteroid resistance COPD bronchial epithelial cells stimulated with toll like receptor 3 agonist
por: Milara, Javier, et al.
Publicado: (2015) -
Differential cytopathogenesis of respiratory syncytial virus prototypic and clinical isolates in primary pediatric bronchial epithelial cells
por: Villenave, Rémi, et al.
Publicado: (2011) -
Metabolic changes during respiratory syncytial virus infection of epithelial cells
por: Martín-Vicente, María, et al.
Publicado: (2020)